48
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

, , , , , , , , & show all
Pages 2341-2348 | Published online: 28 Apr 2017

References

  • PanHJiangTChengNLong non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancerOncotarget2016731499484996027409677
  • ChapmanAMSunKYRuestowPCowanDMMadlAKLung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokersLung Cancer201610212213427987580
  • ShraderMPinoMSBrownGMolecular correlates of gefitinib responsiveness in human bladder cancer cellsMol Cancer Ther20076127728517237287
  • LiuMZhouCZhengJCigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transitionAm J Transl Res20157102026203526692946
  • LiDZhangLZhouJChenHCigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMTLung Cancer201693354226898612
  • VuTJinLDattaPKEffect of cigarette smoking on epithelial to mesenchymal transition (EMT) in lung cancerJ Clin Med201654
  • WilsonCNicholesKBustosDOvercoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionOncotarget20145177328734125193862
  • DuBShimJSTargeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancerMolecules2016217
  • YinHWangYChenWZhongSLiuZZhaoJDrug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLCGene20165941232927581786
  • SinghASettlemanJEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene201029344741475120531305
  • ThomsonSBuckEPettiFEpithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibitionCancer Res200565209455946216230409
  • BaiXYZhangXCYangSQBlockade of hedgehog signaling synergistically increases sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer cell linesPLoS One2016113e014937026943330
  • FrederickBAHelfrichBAColdrenCDEpithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinomaMol Cancer Ther2007661683169117541031
  • XuJYangHZhouXWangHGongLTangCBisdemethoxycurcumin suppresses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expression, and inducing autophagyMol Med Rep20151257603760826459909
  • YanYRXieQLiFEpithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cellsNeuropathology201434212813424112388
  • LiuHZhangHWSunXFTamoxifen-resistant breast cancer cells possess cancer stem-like cell propertiesChin Med J (Engl)2013126163030303423981606
  • ShresthaEHusseinMASavasJNPoly(ADP-ribose) polymerase 1 represses liver X receptor-mediated ABCA1 expression and cholesterol efflux in macrophagesJ Biol Chem201629121111721118427026705
  • ZhangRLiuZLiYWuBLXR agonist regulates the proliferation and apoptosis of human T-Cell acute lymphoblastic leukemia cells via the SOCS3 pathwayInt J Biochem Cell Biol20167818018527422090
  • WuYYuDDHuYLXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationBiochem Biophys Res Commun2015467490090526471306
  • EngelmanJAZejnullahuKMitsudomiTMET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingScience200731658271039104317463250
  • FischerKRDurransALeeSEpithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceNature2015527757947247626560033
  • WareKEHinzTKKleczkoEA mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopOncogenesis20132e3923552882
  • FernandoRIHamiltonDHDominguezCDavidJMMcCampbellKKPalenaCIL-8 signaling is involved in resistance of lung carcinoma cells to erlotinibOncotarget2016727420314204427248176
  • MaJLZengSZhangYDengGLShenHEpithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatinTumour Biol20163756177618426614432
  • WairaguPMParkKHKimJCombined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancerBiochem Biophys Res Commun2014447349049524735536
  • KimHYooSBSunPAlteration of the E-cadherin/beta-catenin complex is an Independent poor prognostic factor in lung adenocarcinomaKorean J Pathol2013471445123483484